220 related articles for article (PubMed ID: 24286853)
1. In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus.
Fabry W; Kock HJ
J Hosp Infect; 2014 Jan; 86(1):68-72. PubMed ID: 24286853
[TBL] [Abstract][Full Text] [Related]
2. Activity of the antiseptic polyhexanide against meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
Fabry W; Reimer C; Azem T; Aepinus C; Kock HJ; Vahlensieck W
J Glob Antimicrob Resist; 2013 Dec; 1(4):195-199. PubMed ID: 27873612
[TBL] [Abstract][Full Text] [Related]
3. Activity of the antiseptic polyhexanide against gram-negative bacteria.
Fabry WH; Kock HJ; Vahlensieck W
Microb Drug Resist; 2014 Apr; 20(2):138-43. PubMed ID: 24192397
[TBL] [Abstract][Full Text] [Related]
4. Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide
Renzoni A; Von Dach E; Landelle C; Diene SM; Manzano C; Gonzales R; Abdelhady W; Randall CP; Bonetti EJ; Baud D; O'Neill AJ; Bayer A; Cherkaoui A; Schrenzel J; Harbarth S; François P
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784678
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotypic relatedness of methicillin resistant Staphylococcus aureus in a tertiary care hospital.
Fomda BA; Thokar MA; Bashir G; Khan A; Kour A; Zahoor D; Ray P
J Postgrad Med; 2014; 60(4):386-9. PubMed ID: 25370547
[TBL] [Abstract][Full Text] [Related]
6.
Hamza M; Nadir M; Mehmood N; Farooq A
Indian J Pharmacol; 2016; 48(6):710-714. PubMed ID: 28066112
[TBL] [Abstract][Full Text] [Related]
7. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates.
Candel FJ; Morales G; Picazo JJ
Rev Esp Quimioter; 2011 Sep; 24(3):127-30. PubMed ID: 21947094
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
10. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
11. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of livestock-associated methicillin-resistant
Dittmann K; Schmidt T; Müller G; Cuny C; Holtfreter S; Troitzsch D; Pfaff P; Hübner NO
Antimicrob Resist Infect Control; 2019; 8():122. PubMed ID: 31367343
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance and molecular epidemiological characteristics of clinical isolates of Staphylococcus aureus in Changsha area.
Zou MX; Zhou RR; Wu WJ; Zhang NJ; Liu WE; Hu FP; Fan XG
Chin Med J (Engl); 2012 Jul; 125(13):2289-94. PubMed ID: 22882850
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
15. Comparative time-kill study of doxycycline, tigecycline, cefazolin and vancomycin against several clones of Staphylococcus aureus.
Herrera M; Mobilia L; Posse G; Limansky A; Ballerini V; Bantar C
Curr Clin Pharmacol; 2013 Nov; 8(4):332-9. PubMed ID: 23590512
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Sader HS; Fritsche TR; Jones RN
Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of the plant-derived compounds 23-methyl-6-O-desmethylauricepyrone and (Z,Z)-5-(trideca-4,7-dienyl)resorcinol and their synergy with antibiotics against methicillin-susceptible and -resistant Staphylococcus aureus.
Joray MB; González ML; Palacios SM; Carpinella MC
J Agric Food Chem; 2011 Nov; 59(21):11534-42. PubMed ID: 21958238
[TBL] [Abstract][Full Text] [Related]
18. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
[TBL] [Abstract][Full Text] [Related]
19. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP
Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals.
Housman ST; Sutherland CA; Nicolau DP
Int J Antimicrob Agents; 2014 Sep; 44(3):235-41. PubMed ID: 25052866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
